A comparative study of c-choline pet and [f]fluorodeoxyglucose pet in the evaluation of lung cancer

Nuclear Medicine Communications

Volumn 24, Issue 4, 2003, Pages 359-366

  Khan, N ^a   Oriuchi, N ^a   Zhang, H ^a   Higuchi, T ^a   Tian, M ^a   Inoue, T ^a   Sato, N ^a   Endo, K ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

C choline PET; FDG PET; Lung cancer

Indexed keywords

CARBON; CHOLINE; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADENOCARCINOMA; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; HUMAN; LUNG TUMOR; LYMPH NODE; LYMPH NODE METASTASIS; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; VALIDATION STUDY;

ADENOCARCINOMA; AGED; CARBON RADIOISOTOPES; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CHOLINE; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 1542650157     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200304000-00004     Document Type: Article

References (34)

1. Aisner J, Whitley NO. Current staging of lung cancer: an overview of current and newer approaches. In: Hansen HH, ed. Basic and clinical concepts of lung cancer. Norwell, MA: Kluwer, 1989: 183-213.
2. Mcloud TC, Bourgouin PM, Greenberg RW, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992; 182: 319-323.
3. Musset D, Grenier P, Carette MF, et al. Primary lung cancer staging: prospective comparative study of MR imaging with CT. Radiology 1986; 160: 607-611.
4. Steinert HC, Hauser M, Allemann F, et al. Non-small cell lung cancer: Nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology 1997; 202: 441-446.
5. Strauss LG, Conti PS. The applications of PET in clinical oncology. J Nucl Med 1991; 32: 623-648.
6. Wahl RL. Positron emission tomography: applications in oncology. In: Murray IPC, Ell PJ, eds. Nuclear medicine in clinical diagnosis and treatment, Vol. 2. New York: Churchill Livingstone, 1994: 801-820.
7. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamanashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33: 1972-1980.
8. 18F-α-methyl tyrosine PET studies in patients with brain tumors. J Nucl Med 1999; 40: 399-405.
9. 11C]choline. J Nucl Med 1997; 38: 842-847.
10. Hara T, Kosaka N, Kondo T, Kishi H, Kobori O. Imaging of brain tumor, lung cancer, esophagus cancer, colon cancer, prostate cancer, and bladder cancer with [C-11]choline. J Nucl Med 1997; 38(suppl): 250.
11. Hara T, Kosaka N, Kishi H. PET imaging of prostate cancer using carbon-11 choline. J Nucl Med 1998; 39: 990-995.
12. 11C-choline PET. J Nucl Med 2000; 41: 1507-1513.
13. 18F]fluoro-2-deoxy-D-glucose using amino polythene supported nucleophilic substitution. J Nucl Med 1986; 27: 235-238.
14. 11C]-choline, a positron-emitting tracer for tumor imaging. Appl Radiat Isot 1999; 50: 531-533.
15. Lowe VJ, Hoffman JM, Delong DM, Patz EF, Coleman RE. Semiquantitative and visual analysis of FDG PET images in pulmonary abnormalities. J Nucl Med 1994; 35: 1771-1776.
16. Mori K, Yokoi K, Saito Y, Tominaga K, Miyazawa N. Diagnosis of mediastinal lymph node metastases in lung cancer. Jpn J Clin Oncol 1992; 22: 35-40.
17. American Thoracic Society. Medical section of the American Lung Association: clinical staging of primary lung cancer. Am Rev Respir Dis 1983; 127: 659-664.
18. Jörg K, Jürgen P, Bernd N, et al. Experience with carbon-11 choline positron emission tomography in prostate carcinoma. Eur J Nucl Med 2000; 27: 1415-1419.
19. 11C]choline in human subjects. Can J Neurol Sci 1985; 12: 214.
20. 3H] and synthesis in vivo of acetylcholine in various tissues of guinea pigs. J Pharmacol Exp Ther 1975; 193: 246-255.
21. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variant. Radiographics 1999; 19: 61-77.
22. 18F-FDG PET in primary diagnosis and staging of patients with thoracic cancer. J Nucl Med 2002; 43: 167-172.
23. 18F]fluoro-deoxyglucose. Ann Thorac Surg 1994; 58: 698-703.
24. Nettelbladt OS, Sundin AE, Valind SO, et al. Combined fluorine-18-FDG and carbon-11-methionine PET for diagnosis of tumors in lung and mediastinum. J Nucl Med 1998; 39: 640-647.
25. Gupta NC, Frank AR, Dewan NA, et al. Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]- fluorine-2-deoxy-D-glucose. Radiology 1992; 184: 441-444.
26. Hoffman EJ, Huang SC, Phelps ME. Quantitation in positron emission computed tomography: effect of object size. J Comput Assist Tomogr 1979; 3: 299-308.
27. Martin WH, Delbeke D, Patton JA, Sandlen MP. Detection of malignancies with SPECT versus PET, with 2-[fluorine-18] flouro-2-deoxy-D-glucose. Radiology 1996; 198: 225-231.
28. Snyder F, Malone B. Acyltransferases and the biosynthesis of pulmonary surfactant lipid in adenoma alveolar type 2 cells. Biochem Biophys Res Commun 1975; 66: 914-919.
29. Rooney SA. The surfactant system and lung phospholipid biochemistry. Am Rev Respir Dis 1985; 131: 439-460.
30. 18F-fluorodeoxyglucose: a novel method of preoperative lymph node staging. Cancer 1999; 86: 1638-1648.
31. 13C-NMR studies of choline and ethanolamine uptake. Biochim Biophys Acta 1991; 1095: 5-16.
32. Katz-Brull R, Degani H. Kinetics of choline transport and phosphorylation in human breast cancer cells: NMR applications of the zero trans method. Anticancer Res 1996; 16: 1375-1380.
33. Wahl RL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB. Staging of mediastinal non-small cell lung cancer with FDG PET, CT and fusion images: preliminary prospective evaluation. Radiology 1994; 191: 371-377.
34. Higashi K, Clavo AC, Wahl RL. Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytrometry and tritiated thymidine uptake. J Nucl Med 1993; 34: 414-419.